Document is current

Any future updates will be listed below

Inebilizumab gegen NMOSD

Crossref DOI link: https://doi.org/10.1007/s15005-021-2178-z

Published Online: 2021-12-17

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark